ArticleOncoimmunology

Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types.

Kristin C Hicks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.